Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Health Investment Group is an active North American healthcare consolidation and investment platform focused on improving health outcomes and system efficiencies, primarily serving aging and chronically ill populations. The group acquires, grows, and operates healthcare companies across the continuum of care, leveraging operational expertise in M&A, scaling businesses, and optimizing value for stakeholders. It does not develop drugs or biologics but invests in or manages companies that deliver healthcare services or technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Health Investment Group.